1. USP, 2019. USP42–NF37 Chapter <3> Topical and Transdermal Drug Products.
2. Performance testing for topical and transdermal drug delivery;Copley;Am. Pharm. Rev.,2016
3. Guidance for industry, nonsterile semisolid dosage forms, scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro release testing and,1997
4. Draft Product Specific Guidance on Acyclovir Ointment,2012
5. Draft product specific guidance on tacrolimus ointment;Revised Sept 2018,2012